WB results showed that the expression of the cancer stem cell markers ALDH1A1, CD44, and Nanog was upregulated when cells were stimulated with LY CM, but this upregulation was diminished when cells were treated with LY + Met CM (Fig. 4B). The gene discussed is CD44; the disease is cancer.